{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T04:10:50Z","timestamp":1707624650209},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T00:00:00Z","timestamp":1152576000000},"content-version":"vor","delay-in-days":6280,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[1989,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sixty\u2010two previously untreated patients with B\u2010cell chronic lymphocytic leukaemia were analysed to study the prognostic value of both the immunologic phenotype and the clinicobiologic characteristics. Univariate studies showed that none of the immunological markers analysed, sheep\u2010rosette, mouse\u2010rosette, slg, and HLA\/DR, CD20, FMC7, CD5, and CD9 antigens, had a significant influence on survival. On the other hand, several clinical and haematological characteristics were identified as being associated with survival: 1) clinical features\u2014presence of lymphadenopathies (<jats:italic>P<\/jats:italic>&lt; .05) and hepatomegaly and\/or splenomegaly (<jats:italic>P<\/jats:italic>&lt; .04); 2) haematologic parameters\u2014presence of anaemia and\/or thrombopenia (<jats:italic>P<\/jats:italic>&lt; .05), the absolute peripheral blood lymphocyte count (<jats:italic>P<\/jats:italic>&lt; .03), and the presence of hypogammaglobulinemia (<jats:italic>P<\/jats:italic>&lt; .08); 3) biochemical parameters\u2014serum uric acid (<jats:italic>P<\/jats:italic>&lt; .03); and 4) bone marrow histopathological features\u2014biopsy pattern (<jats:italic>P<\/jats:italic>&lt; .04) and the percentage of lymphocytes in bone marrow aspirate (<jats:italic>P<\/jats:italic>&lt; .03). Both the Rai staging and the International Workshop on CLL staging systems were effective in identifying groups of patients with significantly different prognoses (<jats:italic>P<\/jats:italic>&lt; .05). Multivariate regression analysis demonstrated that the combination of three clinicopathologic characteristics (bone marrow histopathologic pattern, absolute peripheral blood lymphocyte count, and the presence or not of hypogammaglobulinaemia) had the strongest predictive relationship with survival time.<\/jats:p><jats:p>In summary, our findings show that the clinicobiological and anatomopathologic parameters have much more prognostic relevance than the immunological markers analysed in the present study.<\/jats:p>","DOI":"10.1002\/ajh.2830310105","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T11:46:19Z","timestamp":1172058379000},"page":"26-31","source":"Crossref","is-referenced-by-count":19,"title":["B\u2010cell chronic lymphocytic leukaemia: Prognostic value of the immunophenotype and the clinico\u2010haematological features"],"prefix":"10.1002","volume":"31","author":[{"given":"Alberto","family":"Orfao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. San","family":"Fernando Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agustin","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Consuelo","family":"Canizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Lourdes","family":"Maricato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Lopez","family":"Borrasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,11]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1981.tb02727.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.3.929.929"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1182\/blood.V64.3.642.642","article-title":"Bone marrow histologic pattern. The best single prognostic parameter in chronic lymphocytic leukemia: A multivariate survival analysis of 329 cases","volume":"64","author":"Rozman C","year":"1984","journal-title":"Blood"},{"key":"e_1_2_1_6_2","first-page":"264","article-title":"Staging and therapy of chronic lymphocytic leukemia","volume":"24","author":"Foon KA","year":"1987","journal-title":"Semin Hematol"},{"key":"e_1_2_1_7_2","first-page":"252","article-title":"Prognostic factors in chronic lymphocytic leukemia","volume":"24","author":"Rai KR","year":"1987","journal-title":"Semin Hematol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1986.tb02899.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-2581-9_3"},{"key":"e_1_2_1_10_2","first-page":"193","article-title":"Cell surface markers in hematologic malignancies","volume":"14","author":"Freedman AS","year":"1987","journal-title":"Semin Oncol."},{"key":"e_1_2_1_11_2","first-page":"209","article-title":"Biology of chronic lymphocytic leukemia","volume":"24","author":"Gale RP","year":"1987","journal-title":"Semin Hematol."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92489-8"},{"key":"e_1_2_1_13_2","first-page":"423","article-title":"Influencia de la edad y otros parametros clinico\u2010biologicos en las ganmapatias monoclonales esenciales","volume":"16","author":"Corrales A","year":"1981","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"e_1_2_1_14_2","first-page":"190","article-title":"Estudio de un nuevo anticuerpo monoclonal producido contra una leucemia humana que reconcce antigenos HLA de clase II","volume":"30","author":"Ruiz\u2010Cabello F","year":"1985","journal-title":"Sangre"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110005"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V58.2.406.406","article-title":"Heterogeneity of B\u2010cell leukaemias demonstrated by the monoclonal antibody FMC\u20107","volume":"58","author":"Catovsky D","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_17_2","first-page":"9","volume-title":"Leucocyte Typing. Human Leucocytes Differentiation Antigens Detected by Monoclonal Antibodies","author":"Bernard A","year":"1984"},{"key":"e_1_2_1_18_2","first-page":"655","article-title":"Maturation of human B lymphocytes\u2014Studies with a panel of monoclonal antibodies against membrane antigens","volume":"52","author":"Zola H","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_19_2","volume-title":"BMDP statistical software","author":"Dixon WJ","year":"1983"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/blood.V65.2.340.340","article-title":"Prognostic significance of immunoglobulin phenotype in B\u2010cell chronic lymphocytic leukaemia","volume":"65","author":"Baldini L","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.tb06885.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V64.1.244.244","article-title":"Benign monoclonal B\u2010cell lymphocytosis\u2014A benign variant of CLL: Clinical, immunologic, phenotypic and cytogenetic studies in 20 patients","volume":"64","author":"Han T","year":"1984","journal-title":"Blood"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1977.tb06836.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1978.tb08477.x"},{"key":"e_1_2_1_25_2","first-page":"265","article-title":"Leukaemia cell markers","volume":"37","author":"Harrison DJ","year":"1987","journal-title":"Eur J Haematol"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.tb02364.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","unstructured":"OrfaoA GonzalezM San MiguelJF RiosA CaballeroMD SanzM CalmuntiaMJ GalindoP Lopez BorrascaA: Bone marrow histopathological patterns and immunologic phenotype in B\u2010cell chronic lymphocytic leukaemia. Blut1988 in press.","DOI":"10.1007\/BF00320630"},{"key":"e_1_2_1_28_2","first-page":"39","article-title":"Surface phenotype and clinical stages in B\u2010cell chronic lymphocytic leukaemia","volume":"72","author":"Orfao A","year":"1987","journal-title":"Haematologica (Pavia)"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1983.tb00635.x"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb02189.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1182\/blood.V59.6.1191.1191","article-title":"Staging of chronic lymphocytic leukemia","volume":"59","author":"Baccarani M","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)92207-4"},{"key":"e_1_2_1_33_2","first-page":"490","article-title":"Multivariate analysis of prognostic factors in chronic lymphocytic leukemia","volume":"21","author":"Prokocimer M","year":"1985","journal-title":"Isr J Med Sci"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1972.tb03935.x"},{"key":"e_1_2_1_35_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0308-2261(21)00558-0","article-title":"Prognostic factors in chronic lymphocytic leukemia and their implications for therapy","volume":"6","author":"Phillips EA","year":"1977","journal-title":"Clin Haematol"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1182\/blood.V59.5.1001.1001","article-title":"Prognosis of chronic lymphocytic leukemia: A multivariate survival analysis of 150 cases","volume":"59","author":"Rozman C","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_37_2","first-page":"195","article-title":"Common variant of chronic lymphocytic leukemia is defined by the monoclonal antibody TQ1 (Abstract)","volume":"64","author":"Patrick CW","year":"1984","journal-title":"Blood"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.2830310105","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.2830310105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T03:35:42Z","timestamp":1707622542000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.2830310105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989,5]]}},"alternative-id":["10.1002\/ajh.2830310105"],"URL":"https:\/\/doi.org\/10.1002\/ajh.2830310105","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,5]]}}}